Usefulness of 18F-fluorodeoxyglucose positron emission tomography for detecting ameloblastoma, with special reference to glucose transporter-1 expression.
Otsuru
Mitsunobu
M
Department of Oral and Maxillofacial Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan. ootsuru@is.icc.u-tokai.ac.jp
Aoki
Takayuki
T
Tsukinoki
Keiichi
K
Ota
Yoshihide
Y
Karakida
Kazunari
K
Yamazaki
Hiroshi
H
Yasuda
Masanori
M
Kaneko
Akihiro
A
D000328:Adult; D000564:Ameloblastoma / Q000000981:diagnostic imaging* / Q000473:pathology; D001706:Biopsy; D005260:Female; D019788:Fluorodeoxyglucose F18; D005500:Follow-Up Studies; D051272:Glucose Transporter Type 1 / Q000032:analysis*; D006801:Humans; D007573:Jaw Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D008297:Male; D008339:Mandibular Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology; D008441:Maxillary Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals
D051272:Glucose Transporter Type 1; D019275:Radiopharmaceuticals; C495677:SLC2A1 protein, human; D019788:Fluorodeoxyglucose F18